Acute kidney injury associated with immune checkpoint inhibitor therapy: incidence, risk factors and outcomes

BACKGROUND: Immune checkpoint inhibitors (ICPi) are a novel and promising anti-cancer therapy. There are limited data on the incidence, risk factors and outcomes of acute kidney injury (AKI) in patients receiving ICPi. METHODS: We conducted a cohort study of patients receiving ICPi at our center bet...

Descripción completa

Detalles Bibliográficos
Autores principales: Meraz-Muñoz, Alejandro, Amir, Eitan, Ng, Pamela, Avila-Casado, Carmen, Ragobar, Claire, Chan, Christopher, Kim, Joseph, Wald, Ron, Kitchlu, Abhijat
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Clinical/Translational Cancer Immunotherapy
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7326260/
https://www.ncbi.nlm.nih.gov/pubmed/32601079
http://dx.doi.org/10.1136/jitc-2019-000467

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7326260/
https://www.ncbi.nlm.nih.gov/pubmed/32601079
http://dx.doi.org/10.1136/jitc-2019-000467

Ejemplares similares